Colorectal And GI Cancers
As home genetic testing grows, patients will be bringing their results to physicians for reaction and response. Physicians will need to be proactively prepared.
The researchers found that patients who adhered closely to the guidelines regarding exercise, diet, and excess weight had a 42% lower mortality risk than those who didn't.
A trial involving 573 patients with HCC whose tumors progressed after receiving sorafenib demonstrated the safety and efficacy of Stivarga in this population.
The researchers found that regular aspirin use correlated with reduced risk of total mortality compared with nonregular use (multivariable-adjusted relative risks [RRs], 0.93 and 0.89 for women and men, respectively).
Americans in their early 50s and younger are experiencing significant increases in colorectal cancer incidence, according to research published online February 28 in the Journal of the National Cancer Institute.
Even normal-weight women may be at greater risk for colorectal cancer if they have certain traits, such as elevated triglycerides, low high-density lipoprotein cholesterol, elevated blood pressure, and elevated fasting glucose
Just a half hour a day of moderate physical activity could improve survival odds for patients with metastatic colorectal cancer (CRC), according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from January 19 to 21 in San Francisco.
Prolonged work-related stress in men has been tied to increased chances of cancer at five sites; lung, colon, rectal, stomach and lymphatic.
Addition of cetuximab to chemoradiation (CRT) is associated with a reduction in locoregional failure (LRF) rates in squamous cell carcinoma of the anal canal (SCCAC), according to a study published online January 9 in the Journal of Clinical Oncology.
For patients with advanced unresectable hepatocellular carcinoma, the effect of sorafenib on overall survival (OS) is dependent on patients' hepatitis status, according to a meta-analysis published online January 3 in the Journal of Clinical Oncology.
Bayer has announced that their supplemental New Drug Application (sNDA) for Stivarga (regorafenib tablets) has been granted priority review status by the Food and Drug Administration (FDA).
Definitive chemoradiation (CRT) can potentially cure HIV-associated squamous cell carcinoma of the anal canal (SCCAC), with the addition of cetuximab resulting in less locoregional failure (LRF), according to a study published online December 12 in the Journal of Clinical Oncology.
Administration of cytotoxic T-cells targeting mutant KRAS G12D can induce tumor regression in metastatic colorectal cancer, according to a case report published in the New England Journal of Medicine.
Mylan and Biocon announced the submission of a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for MYL-141O, the proposed biosimilar to trastuzumab.
For patients with type 2 diabetes mellitus (T2DM), use of statins offsets insulin-related cancer risks, according to research published online in the Journal of Internal Medicine.
Yisheng Biopharma has announced that the Food and Drug Administration (FDA) has granted orphan drug designation for its candidate hepatocellular carcinoma treatment, YS-ON-001.
In patients with pathological stage (pStage) II or III gastric cancer, the number of retrieved lymph nodes (RLNs) is an independent poor prognostic factor, according to a study published inthe Journal of Gastroenterology and Hepatology.
Among patients with cancer, researchers found a high prevalence of non-adherence to oral antidiabetic medications and negative consequences tied with non-adherence.
For patients with rectal carcinoma, intraoperative iodine-125 seed implantation brachytherapy is associated with increased risk of anastomotic leakage (AL) and pelvic autonomic nerve dysfunction, according to a study published in the June issue of the Journal of Gastroenterology and Hepatology.
Survival odds for colorectal cancer may depend on which side of the colon the primary tumor develops, according to a study released Wednesday during a media briefing that previewed some of the research to be presented at the upcoming annual meeting of the American Society of Clinical Oncology.